Olon USA, together with Olon S.p.A, will exhibit at CPHI Americas 2025, taking place May 20–22 at the Pennsylvania Convention Center in Philadelphia. Located at Booth 1110, the Olon team will be on-site to meet with partners and new prospects across the pharmaceutical value chain. This event provides a platform to discuss capabilities, explore new collaborations, and share the latest developments across Olon’s global network.
Integrated Expertise from Discovery to Commercialization
Olon USA delivers CDMO and API services with global infrastructure and decades of technical experience. From early-phase development to commercial-scale manufacturing, Olon USA supports small-molecule APIs as well as highly potent compounds. The company’s team of scientific and business development professionals will be available at the booth to discuss full-service solutions tailored to each customer’s project. Members of the Olon Biotech and Generic API teams will also be on-site for discussions.
Expanding Capabilities Through Strategic Growth
Recent strategic acquisitions, including GTP Bioways and HuvePharma Italia Srl and its site in Garessio, have further enhanced Olon’s European CDMO capacity. These additions support increased production flexibility and scale-up options for pharmaceutical innovators and biotech clients. In the U.S., Olon USA continues to expand its capabilities in both development and GMP manufacturing, positioning itself as a key partner in efforts to reshore API production and strengthen domestic supply chains.
Facility Advancements and Regulatory Readiness
Olon USA’s Concord, Ohio site is preparing for an FDA pre-approval inspection, marking a major step forward in its ability to support commercial manufacturing. Investments in quality systems, infrastructure, and staff have been made to meet the requirements of both early-phase programs and long-term commercial production.
Responsive, Science-Driven Problem Solving
Olon differentiates itself with its proactive, problem-solving approach to client engagement. Teams combine deep scientific expertise with practical flexibility to adapt when challenges arise. Whether scaling from milligrams to multi-kilogram production or navigating complex synthesis issues, Olon partners closely with customers to offer solutions, not just updates.
Connect With Olon at Booth 1110
CPHI Americas 2025 presents an opportunity for emerging and established pharmaceutical developers to speak directly with Olon USA and Olon S.p.A representatives. The team encourages companies with ongoing or upcoming API and CDMO needs to schedule a dedicated meeting in advance. Early appointments ensure focused time with business development leads or technical experts to discuss project goals and identify the best path forward.
To initiate a conversation onsite, click here to schedule a meeting with the Olon team at CPHI Americas.